Photo from wikipedia
Basal cell carcinoma (BCC) is one of the most common life-threatening cancer types worldwide due to its aggressiveness 1 . Although recent advances have contributed to understand molecular changes in… Click to show full abstract
Basal cell carcinoma (BCC) is one of the most common life-threatening cancer types worldwide due to its aggressiveness 1 . Although recent advances have contributed to understand molecular changes in BCC, such as microRNA, a class of short non-coding RNAs, that have been reported play a critical role in the regulation of gene expression in BCC patients 2,3 . However, there are still many unknown mechanisms of BCC pathogenesis. An improved understanding of reliable biomarkers and more effective therapeutic targets is necessary to improve patient outcomes. This article is protected by copyright. All rights reserved.
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!